These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 20620135

  • 1. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.
    Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, Zhu HG.
    Exp Mol Pathol; 2010 Dec; 89(3):268-75. PubMed ID: 20620135
    [Abstract] [Full Text] [Related]

  • 2. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI.
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu YZ, Zhu R, Fan J, Pan Q, Li H, Chen Q, Zhu HG.
    J Viral Hepat; 2010 Feb 01; 17(2):98-107. PubMed ID: 19732323
    [Abstract] [Full Text] [Related]

  • 4. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu R, Li BZ, Li H, Ling YQ, Hu XQ, Zhai WR, Zhu HG.
    Pathol Int; 2007 Jun 01; 57(6):328-36. PubMed ID: 17539963
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
    Qiu X, Zhang L, Lu S, Song Y, Lao Y, Hu J, Fan H.
    Oncol Rep; 2014 Jan 01; 31(1):202-8. PubMed ID: 24247422
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A.
    Zheng DL, Zhang L, Cheng N, Xu X, Deng Q, Teng XM, Wang KS, Zhang X, Huang J, Han ZG.
    J Hepatol; 2009 Feb 01; 50(2):377-87. PubMed ID: 19070387
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
    Kim YJ, Jung JK, Lee SY, Jang KL.
    Cancer Lett; 2010 Feb 28; 288(2):226-35. PubMed ID: 19656618
    [Abstract] [Full Text] [Related]

  • 8. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 28; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis.
    Wang DY, Zou LP, Liu XJ, Zhu HG, Zhu R.
    Exp Mol Pathol; 2015 Dec 28; 99(3):399-408. PubMed ID: 26341139
    [Abstract] [Full Text] [Related]

  • 10. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
    Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, Zhang L, Fan H.
    Oncogene; 2013 Jul 04; 32(27):3296-305. PubMed ID: 23604124
    [Abstract] [Full Text] [Related]

  • 11. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway.
    Jung JK, Arora P, Pagano JS, Jang KL.
    Cancer Res; 2007 Jun 15; 67(12):5771-8. PubMed ID: 17575144
    [Abstract] [Full Text] [Related]

  • 12. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN.
    Int J Mol Med; 2007 Jul 15; 20(1):65-73. PubMed ID: 17549390
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation.
    Jung JK, Park SH, Jang KL.
    J Gen Virol; 2010 Feb 15; 91(Pt 2):493-500. PubMed ID: 19828754
    [Abstract] [Full Text] [Related]

  • 14. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
    Park HJ, Yu E, Shim YH.
    Cancer Lett; 2006 Feb 28; 233(2):271-8. PubMed ID: 15885882
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec 28; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 16. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
    Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY.
    Oncol Rep; 2006 Feb 28; 15(2):507-11. PubMed ID: 16391877
    [Abstract] [Full Text] [Related]

  • 17. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
    Li X, Hui AM, Sun L, Hasegawa K, Torzilli G, Minagawa M, Takayama T, Makuuchi M.
    Clin Cancer Res; 2004 Nov 15; 10(22):7484-9. PubMed ID: 15569978
    [Abstract] [Full Text] [Related]

  • 18. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A.
    Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z.
    Cell Signal; 2013 Feb 15; 25(2):439-46. PubMed ID: 23124077
    [Abstract] [Full Text] [Related]

  • 19. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 20. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.